Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU7-186P designates a pseudogene related to U7 small nuclear RNA. Pseudogenes are genomic DNA sequences that resemble functional genes but generally lack the ability to encode functional products. The parent gene, U7 small nuclear RNA (e.g., RNU7-1), is a critical component of the U7 small nuclear ribonucleoprotein (snRNP) complex, which is involved in the processing of histone pre-mRNA necessary for DNA replication and cell cycle progression[1][6]. However, RNU7-186P, as its designation indicates ("pseudogene"), does not produce a functional RNA molecule and is not implicated in any known biological pathway, disease state, or drug mechanism. It is not considered a therapeutic target for any disease[6][2]. RNU7-186P is formally recognized as a pseudogene by the HUGO Gene Nomenclature Committee (HGNC)[2]. It should not be confused with the functional U7 small nuclear RNA genes (like RNU7-1), which have known roles in RNA processing and are implicated in genetic diseases such as Aicardi-Goutières syndrome when mutated[1][3]. There are no known drugs, disease associations, or biomarker utilities for RNU7-186P.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U7 small nuclear 186 pseudogene (RNU7-186P).